The original bill would have required health plans to report detailed information on drug costs to state regulators, such as the most prescribed and most costly medicines. It also would have forced drug makers to give notice of future price increases to companies, pharmacy managers and state agencies that buy prescription drugs, according to California Healthline.
The assembly’s appropriations committee amended the bill by raising the reporting threshold for drug price increases by more than 25 percent to $10,000. It also removed the requirement drugmakers justify their price increases to state regulators.
Sen. Hernandez told California Healthline he plans to continue working with health advocates, labor, education, business groups and community organizations to bring drug pricing reform.
At least 70 California lobbyist groups spent money to support or oppose the legislation, making it one of the most lobbied bills of the session, according to lobbying activity filings obtained by Los Angeles Times.
More articles on finance issues:
Presence Health closes on $1B bond sale
1.4M Americans expected to travel abroad for medical care in 2016
AGS Health opens new facility in India: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
